Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding

被引:6
作者
Cheng, HY
Gillespie, WR
机构
[1] MERCK SHARP & DOHME LTD,DEPT DRUG METAB,W POINT,PA 19486
[2] US FDA,ROCKVILLE,MD 20857
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1996年 / 24卷 / 04期
关键词
volumes of distribution; mean residence time; nonlinear protein binding;
D O I
10.1007/BF02353519
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Based on a generalized model, equations for calculating the mean residence time in the body at single dose (MRT) and at steady state (MRT(ss)), apparent steady-state volume of distribution (<(V)over cap (ss)>), and steady-state volume of distribution (V-ss) are derived for a drug exhibiting nonlinear protein binding. interrelationships between <(V)over cap (ss)> and V-ss as well as between MRT and MRT(ss) are also discussed and illustrated with simulated data. In addition, a method for estimating the central volume of distribution of the bound drug and the sum of the central volume of distribution of the unbound drug and the area under the first moment curve of distribution function for drugs with nonlinear protein binding is proposed and illustrated with both simulated and published data.
引用
收藏
页码:389 / 402
页数:14
相关论文
共 26 条
[1]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[2]   MEAN RESIDENCE TIME CONCEPTS FOR PHARMACOKINETIC SYSTEMS WITH NONLINEAR DRUG ELIMINATION DESCRIBED BY THE MICHAELIS-MENTEN EQUATION [J].
CHENG, HY ;
JUSKO, WJ .
PHARMACEUTICAL RESEARCH, 1988, 5 (03) :156-164
[3]   MEAN RESIDENCE TIME CONCEPTS FOR NONLINEAR PHARMACOKINETIC SYSTEMS [J].
CHENG, HY ;
GILLESPIE, WR ;
JUSKO, WJ .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (08) :627-641
[4]   NUMERICAL SOLUTION OF NONLINEAR PHARMACOKINETIC EQUATIONS - EFFECTS OF PLASMA PROTEIN BINDING ON DRUG DISTRIBUTION AND ELIMINATION [J].
COFFEY, JJ ;
BULLOCK, FJ ;
SCHOENEMANN, PT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (11) :1623-+
[5]  
EVANS GH, 1973, J PHARMACOL EXP THER, V186, P114
[6]   THEOREMS AND IMPLICATIONS OF A MODEL-INDEPENDENT ELIMINATION DISTRIBUTION FUNCTION DECOMPOSITION OF LINEAR AND SOME NONLINEAR DRUG DISPOSITIONS .2. CLEARANCE CONCEPTS APPLIED TO THE EVALUATION OF DISTRIBUTION KINETICS [J].
GILLESPIE, WR ;
VENGPEDERSEN, P .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1985, 13 (04) :441-451
[7]   GENERALIZED PHARMACOKINETIC MODELING FOR DRUGS WITH NONLINEAR BINDING .1. THEORETICAL FRAMEWORK [J].
GILLESPIE, WR .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (01) :99-124
[8]   FACTORS AFFECTING DRUG METABOLISM [J].
GILLETTE, JR .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :43-&
[9]   DISTRIBUTION VOLUME RELATED TO BODY-WEIGHT AND PROTEIN-BINDING [J].
JUSKO, WJ ;
CHIANG, ST .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (04) :469-470
[10]   PLASMA AND TISSUE PROTEIN-BINDING OF DRUGS IN PHARMACOKINETICS [J].
JUSKO, WJ ;
GRETCH, M .
DRUG METABOLISM REVIEWS, 1976, 5 (01) :43-140